June 30, 2026 | Latest News & Updates in Child Neurology Nursing

July 9, 2026

Early risk stratification: HINE global scores predict neurodevelopmental outcomes

A new systematic review and meta-analysis pooling 21 studies and 7,299 infants offers pediatric teams sharper, earlier tools for flagging infants at risk of adverse neurodevelopmental outcomes. Researchers examined Hammersmith Infant Neurological Examination (HINE) global scores collected at 3 months (corrected age), 6, 9, and 12 months, and mapped specific cutoffs to outcomes measured after age 2. The headline finding: a HINE global score below 58 at 3 months predicted cerebral palsy with a sensitivity of 79.6% and specificity of 88.7%. The analysis also identified threshold scores signaling atypical motor development, impaired cognitive, and broader atypical neurodevelopment. The authors conclude that HINE global scores at defined cutoffs provide early, robust risk stratifications supporting timely referral to pediatric rehabilitation during the window when early intervention matters most.


Key Reference

  • Kuo T-J, Chen H-C, Wang Y-H, Tseng S-H. Hammersmith Infant Neurological Examination global scores for predicting neurodevelopmental outcomes after 2 years of age: A systematic review and meta-analysis. First published 30 June 2026. 



Medication safety: caution with sodium channel blockers in HCN1-related epilepsy

A new case series reported worsening of seizures in children with gain-of-function HCN1-related epilepsy treated with antiseizure medications that block sodium channels, leading the authors to advise that sodium-channel-blocking drugs be used with caution in this population. The practical takeaway for bedside teams is the value of confirming the genetic diagnosis before finalizing an antiseizure regimen, since the appropriate mechanism of action can differ by underlying variant—and a medication that helps one epilepsy type can aggravate another.


Key Reference

  • Lelli S, Bleakley LE, Ackermann S, Howell KB, Szczałuba K, Moroni A, Castelli R, Melani F, Reid C, Marini C. Seizure worsening and sodium channel blockers in HCN1-related epilepsies: A case series. *Developmental Medicine & Child Neurology.* First published 25 June 2026. 



Family-centered care: sleep disturbances in children with cerebral palsy affect the whole family

A qualitative descriptive study interviewed children with cerebral palsy who had clinically significant sleep disturbances, along with their parents and siblings, to understand how disrupted sleep affects the whole family unit—not just the patient. Six themes emerged from the interviews, and together they point to a clear need for tailored, multidisciplinary, holistic sleep assessment and intervention, plus dedicated support for the family. The takeaway for care teams is that pediatric sleep problems ripple outward to parents and siblings, so assessment and management should be family-centered rather than child-only.


Key References

  • McCavert M-E, Perra O, McConnell K, Kerr C. Sleep disturbances in children with cerebral palsy, their siblings, and parents: A qualitative descriptive study. *Developmental Medicine & Child Neurology.* First published 25 June 2026.
August 18, 2026
Early EEG changes may predict response to ketogenic diet in pediatric drug-resistant epilepsy A new study examined EEG changes shortly after children with drug-resistant epilepsy started a ketogenic diet. The investigators found that early electroencephalographic changes were associated with subsequent clinical response. This is particularly relevant to epilepsy nurses who educate families starting ketogenic therapy. It highlights the potential value of early EEG biomarkers alongside clinical seizure monitoring , and reinforces the importance of coordinated follow-up between families, nursing teams, dietitians, epileptologists, and EEG services. ACNN Takeaway Could early EEG changes help us identify which children are most likely to benefit from ketogenic therapy? Key Reference Early Electroencephalographic Changes After Ketogenic Diet Therapy in Pediatric Drug-Resistant Epilepsy. Seizure: European Journal of Epilepsy. 2026. Point-of-care EEG is gaining attention in pediatric emergency care A study recently published evaluated clinical selection of point-of-care EEG (POC-EEG) for children presenting to a pediatric emergency department with seizures or altered mental status. This is an especially relevant development for neuroscience nurses because rapid EEG availability could potentially shorten the time to recognition of nonconvulsive seizures and status epilepticus . ACNN Takeaway As POC-EEG becomes more accessible, neuroscience nurses may increasingly be involved in identifying appropriate patients, initiating monitoring, troubleshooting equipment, and recognizing when escalation is needed. Key Reference Toro-Perez J, et al. Components of generalized onset seizures with focal evolution progressing to bilateral tonic-clonic seizures using quantitative electroencephalography in children: Focal or generalized? Epilepsia. 2026. Pediatric epilepsy workforce development is getting attention A new article in Pediatric Neurology examines training pathways, workforce distribution, and professional development in pediatric neurology. This is particularly relevant to ACNN given the ongoing need to develop and retain a highly skilled pediatric neuroscience workforce. There is an important opportunity here to broaden the conversation beyond physician workforce numbers to include nursing, APPs, epilepsy specialists, EEG technologists, educators, and other members of the multidisciplinary team. Key Reference Training pathways, workforce distribution, and professional practice of child neurologists in Brazil: A cross-sectional study with implications for access. Pediatric Neurology. Published online August 6, 2026. Emerging technology stories worth watching Two new preprints are exploring AI approaches to epilepsy: EpiLENS uses patient-specific intracranial EEG patterns to improve localization of the epileptogenic zone across different patients and centers. Another new study explores deep-learning analysis of EEG biomarkers in Fragile X syndrome , focusing on alpha and gamma activity.
June 22, 2026
AI-Based EEG Analysis Moves Closer to Clinical Pediatric Epilepsy Applications Recent reports highlighted advances in machine-learning approaches capable of identifying subtle EEG signatures associated with epilepsy before overt seizure activity is visible. Investigators are now translating these approaches to pediatric clinical datasets, with the goal of developing biomarkers that improve diagnosis and treatment selection. Key References Malik E, et al. Artificial Intelligence and Machine Learning in Pediatric Epilepsy . Neurol Ther. 2026. Mourid MR, et al. Artificial Intelligence in Pediatric Epilepsy Detection . Children (Basel). 2025. Kim H, et al. Application of Artificial Intelligence and Machine Learning in Pediatric Epilepsy . Pediatr Med. 2022. Neural Signature Identified for Predicting Attention Lapses A new report in the neuroscience literature described a neural signature that predicts delayed attentional shifting in both children and adults. Investigators demonstrated that real-time neuromodulation could reduce these lapses, raising future possibilities for neurodevelopmental disorders characterized by attentional dysfunction. Key Reference A Neural Signature to Predict Attention Shifting Delays in Children and Adults . Nature Neuroscience. June 2026. Distinct EEG Biomarkers Continue to Emerge in Genetic Epilepsies Researchers continue to identify syndrome-specific EEG signatures in genetically defined epilepsies. These findings support the growing concept that EEG biomarkers may eventually help classify genetic epilepsies and guide precision therapies. Key References Children's Hospital of Philadelphia Epilepsy NeuroGenetics Initiative (ENGIN), 2025–2026 updates. Collaborative Pediatric Epilepsy Research Networks Expand AI Initiatives At recent neurology meetings, leaders within the Pediatric Epilepsy Research Consortium (PERC) highlighted multicenter projects focused on AI, wearable technologies, seizure prediction, and standardized outcome measures in severe developmental and epileptic encephalopathies. Key Reference Patel A. Expanding Role of AI and Collaboration in Pediatric Epilepsy Research. NeurologyLive, June 2026.
June 9, 2026
ADHD: Cognitive-Motor Exercise Outperforms Standard Exercise A multicenter randomized clinical trial involving 107 children with ADHD found that exercise programs combining movement with cognitive challenges (e.g., rule-switching, inhibitory control tasks, working memory demands) produced greater improvements in executive functioning than aerobic exercise alone. Children showed improvements in inhibitory control and working memory, while both exercise groups demonstrated reductions in ADHD symptoms. \ Why This Matters This study suggests that how children exercise may be as important as how much they exercise. Programs incorporating motor planning, attention, and cognitive flexibility may provide meaningful adjunctive treatment for ADHD. Academic Reference Zhu, F.-L., Dong, Z.-H., Lu, H.-Y., et al. (2026). Integrated cognitive-motor exercise for core symptoms and executive functions in children with attention deficit hyperactivity disorder: A randomized clinical trial. World Journal of Pediatrics. DOI: 10.1007/s12519-026-01019-4. Autism Genetics: Focus Shifts from Individual Genes to Shared Pathways A Yale-led study published in Nature Neuroscience found that numerous autism-associated genes appear to converge on common biological pathways during brain development. Using CRISPR-based models, investigators demonstrated that disrupting different autism-linked genes often resulted in similar downstream developmental effects. Why This Matters Researchers have identified hundreds of autism-associated genes, making individualized therapeutic targeting difficult. The discovery of convergent pathways may offer more practical therapeutic targets. Academic References Fernandez Garcia, M., Retallick-Townsley, K., Balafkan, N., et al. (2026). Convergent developmental pathways among autism-associated genes. Nature Neuroscience.
Show More